HOME >> BIOLOGY >> NEWS
Coexistence of identical competitors: an old doctrine challenged

An illustrious principle in ecology states that no two identical species may coexist: sooner or later all but one will drift to extinction. Researchers from the Beijing Normal University and the University of Helsinki have modeled recent data on fig-pollinating wasps that appear to contradict the old theory.

The model, which is reported in a forthcoming issue of Ecology Letters, is built upon the evolutionary local mate competition theory, which is empirically strongly supported for fig wasps.

Zhang, Lin, and Hanski show how this mechanism leads to a demographic advantage to uncommon species, which helps identical competitors coexist. This prediction accords with the discovery of cryptic species of fig wasps made by researchers using molecular markers.


'"/>

Contact: Kate Stinchcombe
kate.stinchcombe@oxon.blackwellpublishing.com
Blackwell Publishing Ltd.
24-Feb-2004


Page: 1

Related biology news :

1. Close communication between identical twins helps them live longer
2. Genes, neurons, and the Internet found to have some identical organizing principles
3. Cattle, human genomes contain many identical genes
4. Nearly identical controls of immune genes in mice and humans hint at new asthma treatment
5. NIAAA-led study verifies environment-dependent behavioral variation in genetically identical mice
6. Australian overturns 15 years of nano-science doctrine
7. Estrogen doesnt prevent second strokes: protective effects of hormone replacement therapy challenged
8. Jurassic period mammal teeth found; prevailing theories challenged
9. Young rats challenged as model for blood vessel response in older people

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Coexistence identical competitors old doctrine challenged

(Date:6/18/2013)... has awarded $12.7 million to match nine academic ... compounds to explore new treatments for patients in ... dystrophy and schizophrenia. The collaborative pilot initiative, called ... led by the National Center for Advancing Translational ... Fund. , The process of developing a new ...
(Date:6/18/2013)... of breast and ovarian cancers are familial in origin, ... to inherited mutations from the parents in genes such ... PARP inhibitors, which are currently in clinical trials, have ... for personalised cancer treatment, an alternative to standard chemotherapy. ... these patients generate resistance to the drug and, therefore, ...
(Date:6/17/2013)... in the U.S. exposed to high levels of air pollution ... a child with autism as women who lived in areas ... School of Public Health (HSPH). It is the first large ... across the U.S. , "Our findings raise concerns since, depending ... our study lived in areas where risk of autism was ...
Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2
(Date:6/18/2013)... -- RegeneCure announced today the start ... Bone Regeneration (GBR) Dental Membrane as a bone stimulating aid ... encountered when patients have a tooth replaced with a dental ... the implant. Consequently there is often a need to support ... regenerates. The bone substitute material, in turn, needs to be ...
(Date:6/18/2013)... , June 18, 2013 ... investment research firm, announces the initiation of ... French biopharmaceutical company developing and marketing products ... indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... report examining the investment merits of BioAlliance ...
(Date:6/18/2013)... June 18, 2013 Mapi Pharma Ltd. ... and innovative intermediates, and finished dosage forms based on selected ... granted a United States patent for ... Europe for the oral treatment of moderate-to-severe acute ... Intermediate Compounds and Processes for the Preparation of Tapentadol ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/5g3rx5/dna_sequencing ) has announced the addition of ... Markets and Companies " to their offering. ... This report briefly reviews basics of human ... their applications. Current large and small sequencers ...
Breaking Biology Technology:RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
Cached News: